KRISTINE LYNN FISHER

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Acute Care BALTIMORE, MD NPI 1003515792

General Payments — all program years on this page

$944.10

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 34
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $574.22 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $574.2221

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2023 $369.8813
2024 $574.2221

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078707753 Janssen Biotech, Inc. $91.59 11/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1081986652 Telix Pharmaceuticals $14.69 07/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089421722 Daiichi Sankyo Inc. $29.25 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104267449 AstraZeneca Pharmaceuticals LP $30.11 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104773016 AstraZeneca Pharmaceuticals LP $33.37 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105875613 AstraZeneca Pharmaceuticals LP $32.80 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107107189 ABBVIE INC. $18.26 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107107191 ABBVIE INC. $16.34 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114301035 Regeneron Healthcare Solutions, Inc. $19.96 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116251156 GlaxoSmithKline, LLC. $20.27 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128610439 Kite Pharma, Inc. $21.24 03/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131322495 PFIZER INC. $25.85 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133169120 Genentech USA, Inc. $17.96 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137306705 PharmaEssentia USA Corporation $22.40 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137939586 TAIHO ONCOLOGY, INC. $29.12 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138572025 Exelixis Inc. $38.54 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141304853 Incyte Corporation $23.97 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141657954 Merck Sharp & Dohme LLC $22.79 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141854775 Merck Sharp & Dohme LLC $17.75 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150122271 SHIELD THERAPEUTICS INC $20.24 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154829059 Pharmacosmos Therapeutics Inc. $27.72 06/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.